Other: Gold Standard Questionnaire ( DrugBank: Gold )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 291 | Hirschsprung disease, entire colon type | 1 |
291. Hirschsprung disease, entire colon type
Clinical trials : 14 / Drugs : 35 - (DrugBank : 15) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04624334 (ClinicalTrials.gov) | February 25, 2021 | 29/10/2020 | Non-invasive Assessment of Colonic Motility | Electro-Entero-Graphy (EEnG) for Non-invasive Diagnosis of Motility Disorders of the Bowel | Colon Disease;Functional Constipation;Electroenterography;Slow Transit;Hirschsprung Disease | Other: Elektro-Entero-Graphy procedure;Other: EEnG Questionnaire;Other: Gold Standard Questionnaire | Radboud University | NULL | Recruiting | N/A | N/A | All | 80 | Netherlands |